| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3818275
Max Phase: Preclinical
Molecular Formula: C22H22N2O3S
Molecular Weight: 394.50
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=c1onc2n1-c1ccccc1SC2(OCC1CCCCC1)c1ccccc1
Standard InChI: InChI=1S/C22H22N2O3S/c25-21-24-18-13-7-8-14-19(18)28-22(20(24)23-27-21,17-11-5-2-6-12-17)26-15-16-9-3-1-4-10-16/h2,5-8,11-14,16H,1,3-4,9-10,15H2
Standard InChI Key: MLBBYHYNDPKELT-UHFFFAOYSA-N
Associated Targets(non-human)
Left atrium 264 Activities
Right atrium 265 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Aorta 327 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 394.50 | Molecular Weight (Monoisotopic): 394.1351 | AlogP: 4.73 | #Rotatable Bonds: 4 |
| Polar Surface Area: 57.26 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.36 | CX LogD: 6.36 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.64 | Np Likeness Score: -0.63 |
References
| 1. Carosati E, Cosimelli B, Ioan P, Severi E, Katneni K, Chiu FC, Saponara S, Fusi F, Frosini M, Matucci R, Micucci M, Chiarini A, Spinelli D, Budriesi R.. (2016) Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism., 59 (7): [PMID:26962886] [10.1021/acs.jmedchem.6b00030] |
Source
Source(1):